Company Overview and News

 
Crisis in making: Coal shortage shuts 10,500 MW power plants amid rising demand

19h financialexpress
A sudden rise in electricity demand in the wake of inadequate coal supply is precariously pushing power plants towards outages. According to government data, more than 10,500 MW of power plants have cited ‘coal shortage’ for shutting their units down. Out of this, 2,700 MW and 4,210 MW went under outage in September and October, respectively. Most of these plants are located in the states of Maharashtra, Andhra Pradesh, Haryana and Chhattisgarh, all far away from the coal mines, reflecting the inadequacy of the transportation infrastructure to ferry the fuel.
CLNDY 533278 COALINDIA

5
Sensex jumps 267 points tracking global cues, strong earnings

2018-10-17 freepressjournal.in
Mumbai: The equity benchmark Sensex rallied for the fourth straight session Wednesday, and jumped 267 points, on encouraging second quarter earnings by tech major Infosys and positive global cues. The 30- share Sensex soared 267.26 points, or 0.76 per cent, to 35,429.74. It had rallied 1,161 points in the previous three sessions.
BAJAJ-AUTO 500325 RELIANCE 532977 BHRQY 533278 532215 532187 AXISBANK RIGD HDFCBANK 500570 BHARTIARTL TATAMOTORS CLNDY RLNIY YESBANK AXB INDUSINDBK IBN 532648 YYBKY VEDL AXBKY 532454 AXBA ICICIBANK HDB 532174 500180 COALINDIA TTM

5
Sensex logs first fall in 4 days, tanks 383 pts on rupee woes

2018-10-17 freepressjournal.in
Mumbai: The BSE benchmark Sensex snapped its three-day gains, plunging 383 points due to heavy selling mainly in financial and auto stocks as rising crude prices and rupee volatility spooked investors. The flagship index swung nearly 880 points both ways on alternate bouts of buying and selling during the session. The NSE Nifty too fell by 131.70 points to slip below 10,500-mark. Intense selling pressure was witnessed in select counters led by auto, realty and oil&gas stocks.
BAJAJ-AUTO 500325 RELIANCE 532977 BHRQY 533278 532215 535789 500470 532187 AXISBANK RIGD HDFCBANK HEROMOTOCO 500570 BHARTIARTL TATAMOTORS CLNDY RLNIY YESBANK AXB INDUSINDBK 511072 IBN IDKQY 535322 532648 YYBKY VEDL REPCOHOME AXBKY 500182 IBULHSGFIN 532454 AXBA DHFL ICICIBANK TTST TATASTEEL TATLY HDB 532174 500180 HRTQY COALINDIA TTM

 
BCCL Chairman appointment cancelled

2018-10-17 thehindubusinessline
The Centre had on Tuesday cancelled the appointment of A K Singh as the Chairman of Bharat Coking Coal. He had returned to his previous post as Eastern Coalfields' General Manager.
CLNDY 533278 COALINDIA

1
Vedanta had fulfilled its purpose as a listed entity, so we decided to delist: Anil Agarwal

2018-10-16 thehindubusinessline - 1
Vedanta Resources had fulfilled its purpose as a listed entity and hence a decision was taken to delist it, mining moghul Anil Agarwal said.
VED AAUKF LNSTY AAL CLNDY 533278 COALINDIA NGLOY VEDL

 
MCL would achieve coal output target of 162.6 mt: Piyush Goyal

2018-10-15 moneycontrol
Mahanadi Coalfields Ltd (MCL) has the potential to achieve its target of 162.5 million tonne coal for this fiscal, Coal Minister Piyush Goyal said while stressing on long-term mining planning to raise output and ensure supply to power plants.
CLNDY 533278 COALINDIA

 
India to achieve 76% of renewable energy target by 2022: Wood Mackenzie

2018-10-15 financialexpress
India may achieve about 76 percent of the target of having 175 gigawatts of renewable power generation capacity by the scheduled date of 2022 as it faces myriad challenges, Wood Mackenzie said Monday. India is targetting 100 GW of solar capacity and 75 GW of wind power by 2022. “Even with significant cost declines, Wood Mackenzie expects about 76 percent of the target to be met by 2022 and this would still be a noteworthy achievement,” the world’s leading research and consultancy firm said in a report.
CLNDY 533278 COALINDIA

 
India to achieve 76% of renewable energy target by 2022: Wood Mackenzie

2018-10-15 moneycontrol
India may achieve about 76 per cent of the target of having 175 gigawatts of renewable power generation capacity by the scheduled date of 2022 as it faces myriad challenges, Wood Mackenzie said Monday. India is targeting 100 GW of solar capacity and 75 GW of wind power by 2022.
CLNDY 533278 COALINDIA

 
State power cos to get priority in coal supply

2018-10-15 freepressjournal.in
New Delhi : The government has asked Coal India and its subsidiaries to prioritise coal supply to state power producers like NTPC, leaving private electricity plants in a lurch, multiple sources said. The coal ministry has directed CIL to prioritise the coal supply to select central and state government-owned power houses under the pretext of building coal stocks at these plants. Following this, all subsidiaries of Coal India like South Eastern Coalfields Ltd (SECL) have been directed to supply coal to state power generators such as NTPC.
NTPC CLNDY 533278 COALINDIA

1
Sensex slips 71 points on negative economic data, weak rupee

2018-10-15 freepressjournal.in - 1
Mumbai: The BSE benchmark Sensex after reclaiming the 35,000-mark fell 71 points to quote at 34,662.73 Monday, as the IIP slipped to a three-month low in August and retail inflation rose marginally in September. Besides, weak Asian cues on worries over China-Us trade dispute influenced sentiment.
BAJAJ-AUTO ALNSE AXB IBN HINDUNILVR 532977 BHRQY 533278 VEDL 532215 AXBKY 532454 AXBA ICICIBANK 500470 TTST TATASTEEL TATLY AXISBANK 532174 500696 BHARTIARTL CLNDY COALINDIA

 
Sensex slips 71 points on negative economic data, weak rupee

2018-10-15 thehindubusinessline
The BSE benchmark Sensex after reclaiming the 35,000-mark fell 71 points to quote at 34,662.73 Monday, as the IIP slipped to a three-month low in August and retail inflation rose marginally in September.
BAJAJ-AUTO ALNSE AXB IBN HINDUNILVR 532977 BHRQY 533278 VEDL 532215 AXBKY 532454 AXBA ICICIBANK 500470 TTST TATASTEEL TATLY AXISBANK 532174 500696 BHARTIARTL CLNDY COALINDIA

 
Govt to give priority to state power producers for coal supply; private plants in lurch

2018-10-14 moneycontrol
The government has asked Coal India Ltd (CIL) and its subsidiaries to prioritise coal supply to state power producers like NTPC, leaving private electricity plants in a lurch, multiple sources said.
CLNDY 533278 COALINDIA

 
Pricing issues keep Kia off Indian small car market

2018-10-14 thehindubusinessline
Kia Motors India plans to launch its first car in India in the second half of next year, said MD and CEO Kook Hyun Shim - SOMASHEKAR GRN
KIMTF KIMTY CLNDY 533278 COALINDIA

 
Burger Singh aims to open 100 outlets in two years

2018-10-14 thehindubusinessline
Home-grown restaurant chain Burger Singh aims to operate 100 outlets in the next 2-3 years. The company, which recently opened its first “drive-thru” outlet in Gurugram, also plans to raise about ₹50 crore in Series B funding by early next year.
CLNDY 533278 COALINDIA

 
Institutional investors veto reappointment of yet another conglomerate head

2018-10-14 thehindubusinessline
PALAK SHAH For the second time this year, some large institutional shareholders have vetoed the reappointment of a top-level corporate executive as the chairman of a group’s flagship company.
HNDNF HINDALCO CLNDY 533278 COALINDIA 500440

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...